Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
4.205
USD
-0.035 (-0.83%)
Streaming Delayed Price
Updated: 1:06 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Optinose Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Detailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline — What Drives Growth in Today's Competitive Landscape
October 22, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Caseys General Stores, Inc....
From
GlobeNewswire News Releases
Component Price Targets Imply 22% Gains Ahead For Russell 2000
October 19, 2018
The financial media loves to get predictions from experts about where they think a given stock market index is headed. Some experts look at technical analysis patterns, others look at valuation...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program
October 12, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Amid the market mayhem, no biotech or medical ...
Tags
JNCE
MBIO
RHHBY
From
Benzinga
Cramer's lightning round: Waving the red flag on Vodafone's stock
October 11, 2018
Jim Cramer shares his take on callers' favorite stock at lightning speed, including a telecommunications play that's starting to look suspicious.
Tags
Walgreens Boots Alliance Inc
Investment strategy
Jim Cramer
From
CNBC.com News
The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares
October 03, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ...
Tags
News
RLM
Benzinga
From
Benzinga
Optinose to Highlight Data at Two Upcoming Scientific Meetings
October 03, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that data concerning its product XHANCE® will be...
From
GlobeNewswire News Releases
The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares
October 02, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting ...
Tags
NVTR
BDX
RXII
From
Benzinga
Will Insiders Be Tempted To Buy More OPTN At The New 52-Week Low?
September 28, 2018
In trading on Friday, shares of OptiNose Inc (OPTN) touched a new 52-week low of $12.40/share. That's a $17.60 share price drop, or -58.67% decline from the 52-week high of $30.00 set back on...
Tags
Stocks
From
Market News Video
Optinose to Present at the 2018 Cantor Global Healthcare Conference
September 24, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will...
From
GlobeNewswire News Releases
Top Buys by Top Brass: Chief Executive Officer Miller's $154K Bet on OPTN
September 21, 2018
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider...
Tags
Stocks
From
Market News Video
Snatch This Bargain Even Cheaper Than Chief Executive Officer Miller Did
September 20, 2018
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 15, OptiNose Inc's Chief Executive Officer, Peter...
Tags
Stocks
From
Market News Video
Implied PBSM Analyst Target Price: $33
September 18, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
OptiNose Enters Oversold Territory (OPTN)
September 11, 2018
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Investors Land OPTN 35.6% Lower Than Its Secondary Stock Offering
September 11, 2018
Looking back to 97 days ago, OptiNose Inc (OPTN) priced a 5,000,000 share secondary stock offering at $22.25 per share. Buyers in that offering made a considerable investment into the company,...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue
August 15, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
SBBP
RSLS
OPTN
From
Benzinga
Look Under The Hood: PBSM Has 10% Upside
August 15, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
58 Biggest Movers From Yesterday
August 14, 2018
Gainers Truett-Hurst, Inc. (NASDAQ: THST) shares surged 40 percent to close at $1.96 after the company reported the sale of its ...
Tags
VERI
VIPS
XBIO
From
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against OptiNose, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 14, 2018
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against OptiNose, Inc.
From
Business Wire News Releases
Mid-Afternoon Market Update: Switch Drops Following Downbeat Earnings; Truett-Hurst Shares Jump
August 14, 2018
Toward the end of trading Tuesday, the Dow traded up 0.49 percent to 25,311.15 while the NASDAQ climbed 0.58 percent to 7,864.87. The ...
Tags
Markets
THST
Market News
From
Benzinga
INVESTOR ALERT: Investigation of OptiNose Announced by Holzer & Holzer
August 14, 2018
Holzer investigates OptiNose.
From
Business Wire News Releases
OptiNose, Inc. (OPTN) Q2 2018 Earnings Conference Call Transcript
August 14, 2018
OPTN earnings call for the period ending June 30, 2018.
Tags
Market News
UNKNOWN
From
Motley Fool
45 Stocks Moving In Tuesday's Mid-Day Session
August 14, 2018
Gainers Truett-Hurst, Inc. (NASDAQ: THST) jumped 80 percent to $2.52 after the company reported the sale of its wholesale wine ...
Tags
THST
Losers
AMR
From
Benzinga
Mid-Day Market Update: Dow Up Over 100 Points; Veritone Shares Plunge
August 14, 2018
Midway through trading Tuesday, the Dow traded up 0.44 percent to 25,298.47 while the NASDAQ climbed 0.62 percent to 7,867.76. The ...
Tags
PVG
Markets
THST
From
Benzinga
The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut
August 14, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ...
Tags
AKAO
OSIR
Top Stories
From
Benzinga
Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights
August 14, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended June 30, 2018,...
From
GlobeNewswire News Releases
Earnings Scheduled For August 14, 2018
August 13, 2018
Companies Reporting Before The Bell Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.85 per ...
Tags
Markets
ATNX
LMB
From
Benzinga
Oversold Conditions For OptiNose (OPTN)
August 13, 2018
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Benzinga's Top Upgrades, Downgrades For August 8, 2018
August 08, 2018
Top Upgrades Deutsche Bank upgraded Dean Foods Co (NYSE: DF) from Sell to Hold. Dean Foods shares rose 1 percent to $8.12 in ...
Tags
DF
Analyst Ratings
INTU
From
Benzinga
Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018
August 07, 2018
Conference Call and Webcast Scheduled for Tuesday, August 14 at 8:00 a.m. Eastern Time
From
GlobeNewswire News Releases
41 Biggest Movers From Friday
July 22, 2018
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) jumped 73.64 percent to close at $1.25 after the U.S. Department of Veterans Affairs ...
Tags
ACIU
NMRD
GOL
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.